Physician profile
Calvin Rushing
NPI 1497109433
$451,812.08
in general payments reported to CMS, 2019-2025
56 companies · $121K in 2025
The $121K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1,167 · 2020: $1,803 · 2021: $51K · 2022: $96K · 2023: $90K · 2024: $91K · 2025: $121K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $236K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33K · Travel and Lodging: $16K · Food and Beverage: $8,755 · Charitable Contribution: $8,000 · Royalty Or License: $960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $235,995.52 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $32,500.00 |
| Travel and Lodging | $15,691.56 |
| Food and Beverage | $8,754.60 |
| Charitable Contribution | $8,000.00 |
| Royalty Or License | $959.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bone Support INC. | $75,658.19 | 2023-2025 | Ceramentbone Void Filler, Cerament G |
| Flower Orthopedics Coporation | $61,079.36 | 2021-2023 | Zero Profile Interlocking Cortex Screw, 2.7mm X 14mm, T8, Flex-Thread, Fibula Nail, 4.5mm X 180mm, Titanium, Flex-Thread, Fibula Nail, 4.5mm X 130mm, Titanium, Flex-Thread |
| Medshape, INC. | $49,972.02 | 2022-2024 | Dynanail Helix, Washer, 15 Mm, Dynanail Hybrid, Dynanail Mini |
| Fusion Orthopedics USA, LLC | $47,908.35 | 2023-2025 | Metalogix, Bolobutton |
| New Standard Device, LLC Dba Metalogix | $39,244.46 | 2022-2023 | |
| Alafair Biosciences, INC. | $33,404.21 | 2024-2025 | Versawrap |
| Fuse Medical, INC. | $25,000.00 | 2024-2025 | Orbitum Staple System |
| Innovation Technologies INC | $21,915.86 | 2021-2025 | Irrisept |
| Voom Medical Devices, INC. | $15,902.39 | 2024-2025 | Revcon, Revcon Instrument Kit, Sterile, Voom Medical Revcontm Screw System |
| Nvision Biomedical Technologies, INC. | $14,004.91 | 2022-2023 | Foot and Ankle |
| Trilliant Surgical LLC. | $12,325.35 | 2022-2025 | Arsenal Ankle 10 Hole 1/3 Tubular Plate, Arsenal Ankle, Arsenal Sinus Support Plate |
| Linvatec Corporation | $11,287.94 | 2020-2025 | Biobrace 23mm, Hercules Suture Anchor System |
| Exactech, INC. | $6,959.28 | 2021-2023 | |
| F&A Foundation, LLC | $6,309.97 | 2023-2025 | |
| Acera Surgical, INC. | $6,079.94 | 2021-2024 | Restrata Wound Matrix |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| In2bones USA, LLC | $5,418.50 | 2020-2021 | |
| International Life Sciences | $4,667.64 | 2020-2022 | |
| Ortho Solutions INC | $2,789.52 | 2020-2021 | |
| Intelivation Technologies, LLC | $2,500.00 | 2024 | |
| Encore Medical, Lp | $1,303.56 | 2021-2024 | |
| Cdc Medical LLC | $1,167.00 | 2019 | |
| Restor3d, INC. | $993.06 | 2021-2022 | |
| Curvebeam LLC | $800.00 | 2020 | |
| Crossroads Extremity Systems, LLC | $629.05 | 2021 | |
| Stryker Corporation | $604.99 | 2020-2025 | Augment Injectable |
| Cpm Medical Consultants, LLC | $480.79 | 2024-2025 | Orbitum Staple System |
| Ossio INC | $400.00 | 2023 | |
| Orpyx Medical Technologies INC. | $400.00 | 2021 | |
| Medline Industries Lp | $312.35 | 2021-2023 | |
| Treace Medical Concepts, INC. | $243.93 | 2023-2025 | |
| Smith+Nephew, INC. | $243.36 | 2021-2025 | Salto Talaris Total Ankle Prosthesis, Stravix |
| Integra Lifesciences Corporation | $207.32 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medartis INC. | $181.28 | 2023 | Aptus |
| Kerecis Limited | $135.68 | 2021 | |
| Depuy Synthes Sales INC. | $134.64 | 2021-2024 | Monovisc, Orthovisc |
| Acumed LLC | $116.63 | 2022-2023 | Acumed |
| Trimed, INC. | $114.82 | 2022 | |
| Kuros Biosciences USA, INC | $112.50 | 2025 | Magnetos |
| Bioventus LLC | $112.45 | 2024-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Pylant Medical | $109.12 | 2020 | |
| Paragon 28, INC. | $99.25 | 2020 | |
| Orthofix Medical, INC. | $57.16 | 2022-2025 | Physio-Stim |
| Cardiovascular Systems INC. | $49.76 | 2021-2022 | |
| Heron Therapeutics, INC. | $47.71 | 2022-2025 | Zynrelef |
| Organogenesis INC. | $44.66 | 2021 | |
| Arthrosurface Incorporated | $43.37 | 2025 | Toe Motiontm |
| Pacira Pharmaceuticals Incorporated | $38.07 | 2020-2022 | |
| Siemens Medical Solutions USA, INC. | $37.63 | 2024 | Magnetom Free.Max |
| Axogen | $29.35 | 2025 | |
| Biotissue Holdings INC. | $26.56 | 2022 | |
| Davol INC. | $25.08 | 2025 | Arista |
| Abbott Laboratories | $23.17 | 2021 | |
| Electronic Waveform Lab, INC. | $22.94 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $19.95 | 2024 | |
| Paratek Pharmaceuticals, INC. | $17.00 | 2024 | Nuzyra |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$24,902.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$1,514.98 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Calvin Rushing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.